US Bioservices selected by AstraZeneca to dispense IRESSA and TAGRISSO

February 6, 2017

US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, announced today it has been selected by AstraZeneca to dispense IRESSA (gefitinib) and TAGRISSO (osimertinib) for the treatment of advanced non-small cell lung cancer in patients whose tumors foster gene mutations.